These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7331692)

  • 1. [Studies on abnormal fibrinogen].
    Takamatsu J; Iwanaga S
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1203-11. PubMed ID: 7331692
    [No Abstract]   [Full Text] [Related]  

  • 2. A kinetic method for characterization of heterogenous fibrinogen and its application to fibrinogen Grand Rapids, a congenital dysfibrinogenemia.
    Higgins DL; Lewis SD; Penner JA; Shafer JA
    Thromb Haemost; 1982 Oct; 48(2):182-6. PubMed ID: 6217579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary dysfibrinogenaemia: structural and functional studies on three fibrinogen variants.
    Meyer M; Vogel G; Gromnica-Ihle E; Schellenberg I; Ostermann G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):499-502. PubMed ID: 2465961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular structure of abnormal fibrinogen].
    Matsuda M
    Rinsho Byori; 1987 Apr; Spec No 70():148-59. PubMed ID: 3302384
    [No Abstract]   [Full Text] [Related]  

  • 5. A new dysfibrinogenemia: fibrinogen Oslo IV.
    Stormorken H; Brosstad F; Seim H
    Thromb Haemost; 1983 Apr; 49(2):120-2. PubMed ID: 6868008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital abnormal fibrinogens.
    Ménaché D
    Prog Clin Biol Res; 1981; 72():205-20. PubMed ID: 7335649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease.
    Martinez J; Palascak JE; Kwasniak D
    J Clin Invest; 1978 Feb; 61(2):535-8. PubMed ID: 621288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human platelet fibrinogen: a protein different from plasma fibrinogen.
    Soria J; Soria C; Samama M; Poirot E; Kling C
    Pathol Biol (Paris); 1976 Dec; 24 Suppl():15-7. PubMed ID: 796805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibrinogen Bern III: a further case of hereditary fibrinogen variants with substitution A alpha 16 Arg----Cys].
    Furlan M; Leupin L; Biasiutti FD; Lämmle B
    Schweiz Med Wochenschr; 1991 Jul; 121(29):1068-71. PubMed ID: 1891701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysfibrinogenemia (fibrinogen Dusard) associated with impaired fibrin-enhanced plasminogen activation.
    Lijnen HR; Soria J; Soria C; Collen D; Caen JP
    Thromb Haemost; 1984 Feb; 51(1):108-9. PubMed ID: 6539000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complex formation reaction between heparin and fibrinogen in normal subjects and in disease].
    Erzinkian KL; Titova MI; Rozenfel'd MA; Shimkevich LL; Piruzian LA
    Izv Akad Nauk SSSR Biol; 1978; (5):717-22. PubMed ID: 711985
    [No Abstract]   [Full Text] [Related]  

  • 12. Fibrinogen Bergamo I (A alpha 16Arg----Cys): susceptibility towards thrombin following aminoethylation, methylation or carboxamidomethylation of cysteine residues.
    Reber P; Furlan M; Beck EA; Finazzi G; Buelli M; Barbui T
    Thromb Haemost; 1985 Aug; 54(2):390-3. PubMed ID: 4082078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen Irvine: a qualitatively abnormal fibrinogen associated with the predisposition to recurrent visceral and peripheral venous thrombosis.
    Lehmer RR; Elias AN; Capdeville MJ; Brown DR; Branson HE
    J Natl Med Assoc; 1985 Jul; 77(7):561-5. PubMed ID: 4046054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of Fibrinogen Oslo IV by electrospray mass spectrometry.
    Brennan SO; Ridgway H; Stormorken H; Brosstad F; George PM
    Thromb Haemost; 1997 May; 77(5):1040-1. PubMed ID: 9184429
    [No Abstract]   [Full Text] [Related]  

  • 15. "Fibrinogen Tokyo II". An abnormal fibrinogen with an impaired polymerization site on the aligned DD domain of fibrin molecules.
    Matsuda M; Baba M; Morimoto K; Nakamikawa C
    J Clin Invest; 1983 Sep; 72(3):1034-41. PubMed ID: 6886002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Kanazawa: a congenital dysfibrinogenaemia with delayed polymerization having a replacement of proline-18 by leucine in the A alpha-chain.
    Uotani C; Miyata T; Kumabashiri I; Asakura H; Saito M; Matsuda T; Kajiyama S; Iwanaga S
    Blood Coagul Fibrinolysis; 1991 Jun; 2(3):413-7. PubMed ID: 1932527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Kiel: a congenital dysfibrinogenaemia with (A alpha-16 Arg----His) substitution characterized by HPLC without prior isolation of fibrinogen.
    Seydewitz HH; Gram J; Bruhn HD; Witt I
    Blood Coagul Fibrinolysis; 1991 Aug; 2(4):501-6. PubMed ID: 1768762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hereditary dysfibrinogenaemia (fibrinogen Jena)--report of a family study.
    Maak B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):519-22. PubMed ID: 2465965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.
    Haverkate F; Koopman J; Kluft C; D'Angelo A; Cattaneo M; Mannucci PM
    Thromb Haemost; 1986 Feb; 55(1):131-5. PubMed ID: 3705000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogens Bern IV, Bern V and Milano XI: three dysfunctional variants with amino acid substitutions in the thrombin cleavage site of the Aalpha-chain.
    Stucki B; Zenhäusern R; Biedermann B; Baudo F; Redaelli R; Lämmle B; Furlan M
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):93-9. PubMed ID: 10192658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.